Search Count: 4
 |
Crystal Structure Of Human Wdr5 In Complex With N-[(2'-Cyano[1,1'-Biphenyl]-4-Yl)Methyl]-3-Hydroxy-6-Methyl-4-Oxo-4H-Pyran-2-Carboxamide (Compound 1, Wdr5-Myc Ppi Inhibitor)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-28 Classification: ONCOPROTEIN/INHIBITOR Ligands: YJN |
 |
Crystal Structure Of Human Wdr5 In Complex With (1M)-N-[(3,5-Difluoro[1,1'-Biphenyl]-4-Yl)Methyl]-6-Methyl-4-Oxo-1-(Pyridin-3-Yl)-1,4-Dihydropyridazine-3-Carboxamide (Compound 2, Wdr5-Myc Inhibitor)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2023-06-28 Classification: ONCOPROTEIN/INHIBITOR Ligands: YJR |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2023-01-11 Classification: ONCOPROTEIN Ligands: X8N, GOL, SO4, PGE |
 |
Crystal Structure Of Unliganded Human Cd21 Scr1-Scr2 (Complement Receptor Type 2)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2002-07-05 Classification: IMMUNE SYSTEM Ligands: NAG |